Nuklearmedizin 1982; 21(04): 140-144
DOI: 10.1055/s-0037-1620568
Originalarbeiten – Original Articles
Schattauer GmbH

The Diagnostic Application of Radiocolloid Liver Scintigraphy in Breast Carcinoma

Die diagnostische Anwendung der Leberszintigraphie mit Radiokolloiden beim Mammakarzinom
G. Galli
1   From the Institute of Nuclear Medicine
,
C. L. Maini
1   From the Institute of Nuclear Medicine
,
M. Salvatori
1   From the Institute of Nuclear Medicine
,
G. Ausili Cefaro
2   Institute of Radiology, Università Cattolica del Sacro Cuore, Rome, Italy
› Author Affiliations
Further Information

Publication History

Received: 27 May 1982

Publication Date:
10 January 2018 (online)

The authors have reviewed their experiences in determining the presence of liver metastases in 103 patients by radiocolloid scanning. The sensitivity of liver scanning proved to be quite low if the presence of focal defects in the distribution of the tracer was chosen as the diagnostic criterion. The inclusion of less restrictive criteria such as liver enlargement or irregular distribution of the tracer, resulted in a higher sensitivity without lowering the predictive value of a negative scan. Using the latter diagnostic criterion, sensitivity, specificity and accuracy were in the range of 90%. Abnormal liver scans are common in patients classified as T3–T4 or N+ and their chances of being “true positive” are high. Conversely, abnormal scans are seldom found in patients classified as T1–T2 or N0 and probabilities of “false positive” results are high.

Die Autoren analysierten ihre Erfahrungen mit der Bestimmung der Lebermetastasierung mit Radiokolloid-Scanning bei 103 Patienten. Die Sensitivität der Leberszintigraphie war relativ niedrig, wenn die fokalen Speicherungsdefekte innerhalb der Verteilung des Kolloids als einziges diagnostisches Kriterium gewählt wurden. Der Miteinbezug weniger restriktiver Kriterien wie Vergrößerung der Leber oder ungleichmäßige Tracerverteilung brachte eine höhere Sensitivität, ohne den prognostischen Wert eines negativen Scans herabzusetzen. Die Sensitivität, die Spezifität und die Genauigkeit lagen bei Anlegen dieser letzteren, weiter gefaßten diagnostischen Kriterien im 90%Bereich. Abnormale Leberscans waren häufig bei Patienten mit T3–T4 oder N+; bei ihnen war die Wahrscheinlichkeit „richtig positiv” zu sein, hoch. Dagegen waren abnormale Scans bei den als T1–T2 oder N0 klassifizierten Patienten selten und somit in dieser Gruppe die Wahrscheinlichkeit „falsch positiver“ Resultate hoch.

 
  • References

  • 1 Anderson A, Bergdhal L, Johnson L, Sateborg N. E. The role of scintigraphy in detection of liver metastases from gastrointestinal carcinomas. Acta. Chir. Scand 141: 756-758 1975;
  • 2 Bryan P, Dinn W. M, Grossman Z. D. Correlation of computed tomography, gray scale ultrasonography and radionuclide imaging of the liver in detecting space-occupying processes. Radiology 124: 387-393 1977;
  • 3 Castagna J, Benfield J. R, Yamada M, Johnson B. E. The reliability of liver scans and function tests in detecting metastases. Surg. Gynecol. Obstet 134: 463-466 1972;
  • 4 Dalla Palma L. Ecografia, tomografia computerizzata ed angiografia nella diagnostica delle neoplasie del pancreas, del fegato e dell vie biliari. Bilancio critico. Radiol. Med 66: 577-582 1980;
  • 5 Drum D. E. Optimizing the clinical value of hepatic scin-tiphotography. Sem. nucl. Med 8: 346-357 1978;
  • 6 Drum D. E, Beard J. M. Scintigraphic criteria for hepatic metastases from cancer of the colon and breast. J. nucl. Med 17: 677-680 1976;
  • 7 Fee M. J, Prokop E. K, Cameron J. L, Wagner H. N. Liver scanning in patients with suspected abdominal tumor. J. Amer. med. Ass 230: 1675-1677 1974;
  • 8 Galli G. Analisi decisionale e diagnosi assistita. In Galli G. “Il calcolatore elettronico in Medicina Nucleare”, Editrice Libreria Goliardica Parmense, Parma. 1979
  • 9 Jhingran S. G, Jordan L, Jahns M. F, Maynie T. P. Liver scintigrams compared with alkaline phosphatase and BSP determinations in the detection of metastatic carcinoma. J. nucl. Med 12: 227-230 1971;
  • 10 Leyton B, Halpern S, Leopold G. Correlation of ultrasound and colloid scintiscan studies of the normal and diseased liver. J. nucl. Med 14: 27-33 1973;
  • 11 Lunia S, Parthasarathy K. L, Bakoshi S, Bender N. A. An evaluation of 99mTc sulphur colloid liver scintiscans and their usefulness in metastatic work-up: a review of 1424 studies. J. nucl. Med 16: 62-65 1974;
  • 12 Margolis R, Hansen H. H, Muggia F. M, Kanhou-wa S. Diagnosis of liver metastases in bronchogenic carcinoma. Cancer 34: 1825-1829 1974;
  • 13 McCarty R. L, Stephens D. H, Hattery R. R, Sheedy P. F. Hepatic imaging by computed tomography: a comparison with 99Tc-sulfur colloid, ultrasonography and angiography. Radiol. Clin. North. Am 17: 137-151 1979;
  • 14 Montesi A, Busilacchi P, Giuseppetti G. M, Cianci G, Bazzocchi M, Maffessanti M, Rizzato e G. Ecotomografia ed angiografia nella diagnosi delle neoplasie secondarie del fegato. Radiol. Med 66: 591-595 1980;
  • 15 Passariello R, Simonetti G, Rossi P, Cara L, Franchi e G. Tomografia computerizzata e angiografia nelle metastasi epatiche. Radiol. Med 66: 597-600 1980;
  • 16 Rodari A. Le tecniche medico-nucleari nella diagnosi dei tumori epatici. In: U. Veronesi e coll. “Progressi diagnostici in Oncologia”. Ed Ambrosiana, Milano; pag. 159-167 1980
  • 17 Ruiter D. J, Byck W, Pawels E. K. J, Rakonis W. K, Spaander P. J. Correlation of scintigraphy with short interval autopsy in malignant focal liver disease. Cancer 39: 172-177 1977;
  • 18 Scherer V, Rothe R, Eisenberg J, Schildberg F. W, Meister P, Lissauer J. Diagnostic accuracy of CT in cir-cumscript liver disease. Am. J. Roentg 130: 711-714 1978;
  • 19 Sears H. F, Gerber F. H, Sturtz D. L, Fouty W. J. Liver scan and carcinoma of the breast. Surg. Gynec. Obst 140: 490-511 1975;
  • 20 Snow J. H, Goldstein H. M, Wallace S. Comparison of scintigraphy, sonography and CT in the evaluation of hepatic neoplasms. Am. J. Roentg 132: 915-918 1979;
  • 21 Wilson F. E, Preston D. F, Overhald E. L. Detection of hepatic neoplasms. J. Amer. med. Ass 209: 676-679 1969;